Ch4) PLASMA PROTEIN BINDING (SAQ)

Ch4) BIOTRANSFORMATION
Ch4) FIRST PASS METABOLISM (SAQ)
Ch4) PROLONGATION OF DRUG ACTION (SAQ)
Ch5) THERAPEUTIC INDEX (SAQ)
Ch5) SYNERGISM (SAQ)
Ch5) ANTAGONISM (SAQ)
Ch6) FACTORS MODIFYING DRUG ACTION(LAQ)
Ch6) ADVERSE DRUG EFFECT (LAQ/SAQ)

SIDEEFFECTS
SECONDARY EFFECTS
POISONING
Ch6) TERATOGENECITY (SAQ)
Section 2
ANTICHOLINESTERES
REVERSIBLE
IRREVERSIBLE
PHARMACOLOGICAL ACTION
PHARMACOKINETICS
USES
TREATMENT
ANTICHOLINESTERASE POISONING
Ch 7) CHOLINERGIC TRANSMISSION
Cholinreceptors
Cholinergic Drugs
Action
Uses
Cholinomimetic
Ch 8) ANTICHOLINERGIC DRUG
Classification
Pharmacological action
(Hyoscine butyl bromide, Iprotopium bromide,Dycyclomine)
Uses
Treatment and Contraction
Adverse Effects

Ch9) ADRENERGIC DRUGS

-Action
Table 9.5,9.6
Administration and Preparation
Adverse Effects
Ch9) THERAPEUTIC CLASSIFICATION OF DRUGS
Dopamine
Amphetamine
Phenyleprine
Ch9) NASAL Decongestion
Therapeutic Uses
Ch 7) ALPHA ADRENERGIC BLOCKING DRUGS
Classification
Phenoxybenzamine/Phentolamine
Uses of ALPHA blockers
(Pheochromocytoma, Benign Hypertrophy of prostate)

Beta ADRENERGIC BLOCKING DRUGS

Classification
Actions
Adverse Effects

Alpha+Beta Adrenergic blockers

Timolol,Betaxolol,Latanoprost,Dorzolamide